New Delhi: The CBI has registered an FIR against former Mumbai Police Commissioner Sanjay Pandey and former MD and CEO of NSE Chitra Ramkrishna for the alleged illegal phone tapping of stock market employees by the former’s Information Technology company.
The CBI action comes following a complaint from the Union Home Ministry, officials were quoted as saying.
In addition to Pandey and Ramkrishna, the CBI has also named another former National Stock Exchange (NSE) CEO and MD Ravi Narain in the case. The Central Bureau of Investigation (CBI) is conducting searches at 10 locations in Mumbai, Pune, and other cities in connection with the FIR against Pandey, officials said, The New Indian Express reported quoting PTI.
It is alleged that iSec Securities Pvt. Ltd, one firm amongst a few others that conducted a security audit of NSE had illegally tapped phones of NSE employees during 2009-17, the CBI said. The company had done an audit around the time the co-location irregularities are alleged to have taken place.
The company was incorporated by Pandey in March 2001 and he quit as its director in May 2006. His son and mother later took charge of the company. The police officer, who studied at IIT-Kanpur and Harvard University, is understood to have established the company after he resigned from service.
His resignation was not accepted by the state government and he rejoined but was not immediately given a posting.
Bhubaneswar: The Congress has nominated Biswabhusan Das, who had returned to the party from BJP…
New Delhi: A man in Bihar married his mother-in-law after the family after he had…
Bhubaneswar: The Railway Protection Force (RPF) seized more than 100 turtles while being transported in…
Berhampur: In order to help the college and university teachers in their research activities in…
New Delhi: The Congress party on Tuesday released another list of candidates for the ongoing…
New Delhi: A former Miss Ecuador contestant was shot and killed by two gunmen in…
Bhubaneswar: Another former MLA of BJD in Odisha resigned from the party on Tuesday after…
New Delhi: AstraZeneca's startling revelation about the rare side effects of their Covishield vaccine has…